|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.20 CNY | +0.74% |
|
+5.88% | +3.42% |
Company Valuation: Hubei Jumpcan Pharmaceutical Co., Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 17,969 | 25,173 | 25,092 | 28,972 | 26,803 | 25,061 | 25,061 |
| Change | - | 40.09% | -0.32% | 15.46% | -7.49% | -6.5% | 0% |
| Enterprise Value (EV) | 17,969 | 25,173 | 25,092 | 28,972 | 26,803 | 25,061 | 25,061 |
| Change | - | 40.09% | -0.32% | 15.46% | -7.49% | -6.5% | 0% |
| P/E ratio | 13.2x | 15.2x | 11.4x | 10.2x | 10.5x | - | - |
| PBR | 2.35x | 2.78x | 2.21x | 2.17x | 1.82x | - | - |
| PEG | - | 0.7x | 0.4x | 0.4x | -1x | - | - |
| Capitalization / Revenue | 29,14,764x | 32,99,025x | 27,89,126x | 30,00,909x | 33,43,334x | - | - |
| EV / Revenue | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - |
| EV / EBIT | - | - | - | - | - | - | - |
| EV / FCF | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - |
| EPS 2 | 1.53 | 1.87 | 2.39 | 3.08 | 2.76 | - | - |
| Distribution rate | - | - | - | - | - | - | - |
| Net sales | 6,165 | 7,631 | 8,996 | 9,655 | 8,017 | - | - |
| EBITDA | - | 2,226 | 2,740 | 3,209 | - | - | - |
| EBIT | 1,469 | 1,871 | 2,423 | 3,258 | 2,863 | - | - |
| Net income 1 | 1,277 | 1,664 | 2,171 | 2,823 | 2,532 | 1,547 | 1,724 |
| Net Debt | - | - | - | - | - | - | - |
| Reference price 2 | 20.23 | 28.34 | 27.22 | 31.43 | 29.08 | 27.20 | 27.20 |
| Nbr of stocks (in thousands) | 8,88,257 | 8,88,259 | 9,21,822 | 9,21,807 | 9,21,704 | 9,21,344 | 9,21,344 |
| Announcement Date | 16/04/21 | 19/01/22 | 19/01/23 | 09/04/24 | 25/04/25 | - | - |
1CNY in Million2CNY
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 362.64Cr | ||
| 29.14x | 1.54x | 9.94x | 3.13% | 616.81Cr | ||
| 20.18x | 4.4x | 14.7x | 4.58% | 513.74Cr | ||
| 15.45x | - | - | - | 452.24Cr | ||
| 23.91x | 3.18x | 18.07x | 1.41% | 430.57Cr | ||
| 18.73x | 2.21x | 9.67x | 4.78% | 323.41Cr | ||
| 15.9x | 2.89x | 12.32x | 4.97% | 179.85Cr | ||
| 18.66x | - | - | 4.4% | 173.14Cr | ||
| Average | 20.28x | 2.84x | 12.94x | 3.88% | 381.55Cr | |
| Weighted average by Cap. | 21.48x | 2.81x | 12.99x | 3.62% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- 600566 Stock
- Valuation Hubei Jumpcan Pharmaceutical Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















